Schnebli HP - Search Results

1

Chelator-induced iron excretion in iron-overloaded marmosets.

Sergejew T, Forgiarini P, Schnebli HP. Sergejew T, et al. Among authors: schnebli hp. Br J Haematol. 2000 Sep;110(4):985-92. doi: 10.1046/j.1365-2141.2000.02260.x. Br J Haematol. 2000. PMID: 11054093 Free article.

2

ICL670A: preclinical profile.

Nick H, Wong A, Acklin P, Faller B, Jin Y, Lattmann R, Sergejew T, Hauffe S, Thomas H, Schnebli HP. Nick H, et al. Among authors: schnebli hp. Adv Exp Med Biol. 2002;509:185-203. doi: 10.1007/978-1-4615-0593-8_10. Adv Exp Med Biol. 2002. PMID: 12572995 No abstract available.

3

Toxicity of oral iron chelator L1.

Berdoukas V, Bentley P, Frost H, Schnebli HP. Berdoukas V, et al. Among authors: schnebli hp. Lancet. 1993 Apr 24;341(8852):1088. doi: 10.1016/0140-6736(93)92443-w. Lancet. 1993. PMID: 8096974 No abstract available.

4

Future of oral iron chelator deferiprone (L1).

Pfannkuch F, Bentley P, Schnebli HP. Pfannkuch F, et al. Among authors: schnebli hp. Lancet. 1993 Jun 5;341(8858):1480. Lancet. 1993. PMID: 8099178 No abstract available.

5

Thiosulphate-sulphur transferase (rhodanese) deficiency in Leber's hereditary optic atrophy.

Cagianut B, Rhyner K, Furrier W, Schnebli HP. Cagianut B, et al. Among authors: schnebli hp. Lancet. 1981 Oct 31;2(8253):981-2. doi: 10.1016/s0140-6736(81)91171-5. Lancet. 1981. PMID: 6117741 No abstract available.

6

Decreased thiosulfate sulfur transferase (rhodanese) in Leber's hereditary optic atrophy.

Cagianut B, Schnebli HP, Rhyner K, Furrer J. Cagianut B, et al. Among authors: schnebli hp. Klin Wochenschr. 1984 Sep 17;62(18):850-4. doi: 10.1007/BF01712000. Klin Wochenschr. 1984. PMID: 6593495

7

[Thiosulfate-sulfur transferase deficiency in Leber's hereditary optic atrophy ].

Cagianut B, Schnebli HP, Rhyner K, Furrer W. Cagianut B, et al. Among authors: schnebli hp. Klin Monbl Augenheilkd. 1982 Jul;181(1):32-5. doi: 10.1055/s-2008-1055162. Klin Monbl Augenheilkd. 1982. PMID: 6956776 German. No abstract available.

8

4-.

Heinz U, Hegetschweiler K, Acklin P, Faller B, Lattmann R, Schnebli HP. Heinz U, et al. Among authors: schnebli hp. Angew Chem Int Ed Engl. 1999 Sep;38(17):2568-2570. Angew Chem Int Ed Engl. 1999. PMID: 10508341

9

Selective oxidation of methionyl residues in the human recombinant secretory leukocyte proteinase inhibitor. Effect on the inhibitor binding properties.

Tomova S, Cutruzzolà F, Barra D, Amiconi G, Ascenzi P, Djinović Carugo K, Menegatti E, Sarti P, Schnebli HP, Bolognesi M. Tomova S, et al. Among authors: schnebli hp. J Mol Recognit. 1994 Mar;7(1):31-7. doi: 10.1002/jmr.300070105. J Mol Recognit. 1994. PMID: 7986566

10

Structure of the proteinase inhibitor eglin c with hydrolysed reactive centre at 2.0 A resolution.

Betzel C, Dauter Z, Genov N, Lamzin V, Navaza J, Schnebli HP, Visanji M, Wilson KS. Betzel C, et al. Among authors: schnebli hp. FEBS Lett. 1993 Feb 15;317(3):185-8. doi: 10.1016/0014-5793(93)81273-3. FEBS Lett. 1993. PMID: 8425603 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page